We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 81-100 of 10,000 results
  1. A novel colorectal cancer test combining microsatellite instability and BRAF/RAS analysis: Clinical validation and impact on Lynch syndrome screening

    Background

    Lynch syndrome (LS) is under-diagnosed. UK National Institute for Health and Care Excellence guidelines recommend multistep molecular...

    Richard Gallon, Patricia Herrero-Belmonte, ... Michael S. Jackson in BJC Reports
    Article Open access 01 July 2024
  2. Highly Sensitive Detection of PIK3CA Mutations by Loo**-Out Probes-Based Melting Curve Analysis

    PIK3CA mutations have important therapeutic and prognostic implications in various cancer types. However, highly sensitive detection of PIK3CA ...

    Boheng Xu, Yan** Lan, ... Qingge Li in Biochemical Genetics
    Article 30 May 2023
  3. Cost-effectiveness of latent tuberculosis infection testing and treatment with 6-week regimen among key population in rural communities in China: a decision analysis study

    Purpose

    Several model studies suggested the implementation of latent tuberculosis infection (LTBI) testing and treatment could greatly reduce the...

    Xuefang Cao, Tonglei Guo, ... Lei Gao in European Journal of Clinical Microbiology & Infectious Diseases
    Article 22 February 2024
  4. Clinical and financial impacts of abnormal liver biochemistry after liver transplantation

    Objective

    After liver transplant (LT) , many investigations are needed to evaluate abnormal liver function test (LFT), which has poor specificity for...

    Dee Zhen Lim, Nicholas Low, ... Muralidharan Vijayaragavan in BMC Research Notes
    Article Open access 27 January 2023
  5. Cluster analysis of cancer knowledge, attitudes and behaviors in the Moroccan population

    Background

    Cancer has become a major health concern due to the increasing morbidity and mortality rates, and its negative social, economic...

    Mohamed Khalis, Imad Elbadisy, ... Inge Huybrechts in BMC Cancer
    Article Open access 01 June 2024
  6. A Bibliometric Analysis of the Spatial Transcriptomics Literature from 2006 to 2023

    In recent years, spatial transcriptomics (ST) research has become a popular field of study and has shown great potential in medicine. However, there...

    Shu-Han Zhao, **n-Yu Ji, ... Shuai Shi in Cellular and Molecular Neurobiology
    Article Open access 10 June 2024
  7. Impact of Introducing Infliximab Biosimilars on Total Infliximab Consumption and Originator Infliximab Prices in Eight Regions: An Interrupted Time-Series Analysis

    Objective

    We aimed to assess whether the introduction of the first infliximab biosimilar was associated with changes in overall infliximab consumption...

    Kuan Peng, Joseph E. Blais, ... Xue Li in BioDrugs
    Article Open access 23 March 2023
  8. Rapid genomic sequencing for genetic disease diagnosis and therapy in intensive care units: a review

    Single locus (Mendelian) diseases are a leading cause of childhood hospitalization, intensive care unit (ICU) admission, mortality, and healthcare...

    Stephen F. Kingsmore, Russell Nofsinger, Kasia Ellsworth in npj Genomic Medicine
    Article Open access 27 February 2024
  9. A Cost-Effectiveness Analysis of Biomarkers for Risk Prediction in Atrial Fibrillation

    Rationale

    Atrial fibrillation (AF) is associated with an increased risk of thromboembolism. This risk is currently assessed with scoring systems based...

    Gisèle Nakhlé, Jean-Claude Tardif, ... Jacques LeLorier in Molecular Diagnosis & Therapy
    Article Open access 31 January 2023
  10. Role of antiangiogenic agents in first-line treatment for advanced NSCLC in the era of immunotherapy

    Background & objective

    “Anti-angiogenetic drugs plus chemotherapy” (anti-angio-chemo) and “immune checkpoint inhibitors plus chemotherapy” (ICI-chemo)...

    Lan-Lan Pang, Jia-Di Gan, ... Wen-Feng Fang in BMC Cancer
    Article Open access 21 January 2023
  11. Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma

    Background

    Recurrence is common in glioblastoma multiforme (GBM) because of the infiltrative, residual cells in the tumor margin. Standard therapy for...

    Hanwool Jeon, Joonho Byun, ... Seungjoo Lee in Journal of Translational Medicine
    Article Open access 02 February 2023
  12. Factors Associated with Biosimilar Exclusions and Step Therapy Restrictions Among US Commercial Health Plans

    Background

    Biosimilars have been introduced with the goal of competing with high-priced biologic therapies, yet their adoption has been slower than...

    Tianzhou Yu, Shihan **, ... Jakub P. Hlávka in BioDrugs
    Article Open access 01 April 2023
  13. Consensus Head Acceleration Measurement Practices (CHAMP): Study Design and Statistical Analysis

    Head impact measurement devices enable opportunities to collect impact data directly from humans to study topics like concussion biomechanics, head...

    Steve Rowson, Jason Mihalik, ... Jim Funk in Annals of Biomedical Engineering
    Article Open access 17 October 2022
  14. Continuing the sequence? Towards an economic evaluation of whole genome sequencing for the diagnosis of rare diseases in Scotland

    Novel developments in genomic medicine may reduce the length of the diagnostic odyssey for patients with rare diseases. Health providers must thus...

    Michael Abbott, Lynda McKenzie, ... Mandy Ryan in Journal of Community Genetics
    Article Open access 20 August 2021
  15. The prognostic role of tumor mutation burden on survival of breast cancer: a systematic review and meta-analysis

    Background

    As a potential genetic biomarker, tumor mutation burden (TMB) has made progress in numerous tumors. There are limited data regarding TMB...

    Liyuan Ke, Su Li, Hongxia Cui in BMC Cancer
    Article Open access 17 November 2022
  16. Isopropyl alcohol inhalation versus 5-HT3 antagonists for treatment of nausea: a meta-analysis of randomised controlled trials

    Purpose

    Nausea is a common and unpleasant sensation for which current therapies such as serotonin (5-HT 3 ) antagonists are often ineffective, while...

    James S. Kimber, Joshua G. Kovoor, ... David I. Watson in European Journal of Clinical Pharmacology
    Article Open access 14 September 2023
  17. Immunotherapy Guided by Immunohistochemistry PD-L1 Testing for Patients with NSCLC: A Microsimulation Model-Based Effectiveness and Cost-Effectiveness Analysis

    Background

    On the basis of immunohistochemistry PD-L1 testing results, patients with advanced non-small cell lung cancer (NSCLC) are treated...

    Mingjun Rui, Yingcheng Wang, ... Zhengyang Fei in BioDrugs
    Article 04 October 2023
  18. C-reactive protein point of care testing in the management of acute respiratory infections in the Vietnamese primary healthcare setting – a cost benefit analysis

    Aim

    We assess the cost-benefit implications of C-reactive protein (CRP) testing in reducing antibiotic prescription for acute respiratory infection in...

    Yoel Lubell, Nga T. T. Do, ... Heiman F. L. Wertheim in Antimicrobial Resistance & Infection Control
    Article Open access 04 October 2018
  19. Critical analysis of the prescription and evaluation of protein kinase inhibitors for oncology in Germany

    The prices of oncology drugs have been rising progressively in recent years. Despite accounting for only a small share of prescriptions, oncology...

    Caecilia S. Obst, Roland Seifert in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article Open access 04 April 2023
  20. Hit it hard: qualitative patient perspectives on the optimisation of immune checkpoint inhibition

    Background

    Immune checkpoint inhibitors have transformed the treatment landscape of many cancers, including melanoma and renal cell carcinoma (RCC)....

    Sophie Merrick, Hannah L. Rush, ... Duncan C. Gilbert in British Journal of Cancer
    Article Open access 17 June 2024
Did you find what you were looking for? Share feedback.